Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

被引：0
|
作者：
Takuya Maeda
Azusa Hiura
Jiro Uehara
Rino Toyoshima
Tomoe Nakagawa
Koji Yoshino
机构：
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Dermatologic Oncology
来源：
European Journal of Dermatology | 2021年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：662 / 664
页数：2
相关论文
共 50 条
  • [41] Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab
    Zaremba, A.
    Chorti, E.
    Jockenhoefer, F.
    Albrecht, M.
    Placke, J. M.
    Knispel, S.
    Schadendorf, D.
    Hadaschik, E.
    Roesch, A.
    Ugurel, S.
    Zimmer, L.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 38 - 38
  • [42] Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
    Patel, Sapna P.
    Sheth, Rahul A.
    Davis, Christina
    Medina, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08)
  • [43] Real-world evidence in melanoma: A national, prospective, non-interventional study (NIS) of nivolumab monotherapy or in combination with ipilimumab in patients with advanced (unresected or metastatic) melanoma (NICO)
    Eigentler, T.
    Gutzmer, R.
    Mohr, P.
    Kaatz, M.
    Pfohler, C.
    Terheyden, P.
    Ulrich, J.
    Utikal, J.
    Zimmer, L.
    Schadendorf, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 159 - 159
  • [44] Real-world efficacy of relatlimab and nivolumab in advanced or resectable melanoma
    Karapetyan, L.
    Aflatooni, S.
    Ward, K.
    Withycombe, B.
    Kalos, D.
    Mo, Q.
    Eroglu, Z.
    Brohl, A. S.
    Markowitz, J.
    Tarhini, A.
    Messina, J.
    Tsai, K. Y.
    Perez, M.
    Zager, J. S.
    Sarnaik, A.
    Neves, R. I.
    Sondak, V.
    Khushalani, N. I.
    ANNALS OF ONCOLOGY, 2024, 35 : S731 - S731
  • [45] Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
    Bocquet-Tremoureux, Solene
    Scharbarg, Emeric
    Nguyen, Jean-Michel
    Varey, Emilie
    Quereux, Gaelle
    Saint-Jean, Melanie
    Peuvrel, Lucie
    Khammari, Amir
    Dreno, Brigitte
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (03) : 315 - 321
  • [46] Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study
    Serra-Bellver, Patricio
    Versluis, Judith M.
    Oberoi, Honey K.
    Zhou, Cong
    Slattery, Timothy D.
    Khan, Yasir
    Patrinely, James R.
    da Silva, Ines Pires
    Martinez-Vila, C.
    Cook, Natalie
    Graham, Donna M.
    Carlino, Matteo S.
    Menzies, Alexander M.
    Arance, Ana M.
    Johnson, Douglas B.
    Long, Georgina, V
    Pickering, Lisa
    Larkin, James M. G.
    Blank, Christian U.
    Lorigan, Paul
    EUROPEAN JOURNAL OF CANCER, 2022, 176 : 121 - 132
  • [47] Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
    Solène Bocquet-Tremoureux
    Emeric Scharbarg
    Jean-Michel Nguyen
    Emilie Varey
    Gaëlle Quereux
    Melanie Saint-Jean
    Lucie Peuvrel
    Amir Khammari
    Brigitte Dreno
    European Journal of Dermatology, 2019, 29 : 315 - 321
  • [48] Trial in progress: clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401
    Dummer, R.
    Gutzmer, R.
    Corrie, P.
    Millward, M.
    Murzhenko, A.
    Maio, M.
    MELANOMA RESEARCH, 2016, 26 : E43 - E43
  • [49] TEMPORAL TRENDS IN ADVERSE EVENT COSTS WITH NIVOLUMAB plus RELATLIMAB COMBINATION THERAPY OR NIVOLUMAB MONOTHERAPY FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA
    Garcia-Horton, V
    Zhou, Z. Y.
    Moshyk, A.
    Rosenblatt, L. C.
    Patel, D.
    Xin, Y.
    Wang, Q.
    Christensen, D.
    Palaia, J.
    VALUE IN HEALTH, 2023, 26 (06) : S108 - S108
  • [50] The efficacy and safety of combined ipilimumab and nivolumab versus ipilimumab in patients with Stage III/IV unresectable melanoma: A systematic review and meta-analysis
    Zhu, Yuqing
    Cheng, Hui
    Zhong, Minhong
    Hu, Yijie
    Li, Qiushuang
    Gao, Xiangfu
    Liu, Shan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (07) : 1679 - +
12345